Literature DB >> 26255218

Utility of the Logistic Clinical Syntax Score in the Prediction of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention.

Derya Ozturk1, Omer Celik2, Mehmet Erturk2, Ali Kemal Kalkan2, Fatih Uzun2, Ibrahim Faruk Akturk2, Fatih Akin3, Aydin Yildirim2.   

Abstract

BACKGROUND: The Logistic Clinical Syntax Score (log CSS) is a combined risk scoring system that includes clinical and anatomic parameters; it has been found to be effective for the prediction of mortality in patients with ST-elevation myocardial infarction (STEMI). The aim of the present study was to assess whether the log CSS was associated with the development of contrast-induced nephropathy (CIN) in patients who underwent primary percutaneous coronary intervention (pPCI).
METHODS: A total of 930 patients with STEMI undergoing pPCI between January 2012 and August 2013 were included prospectively. The patients were grouped according to the development of CIN. Either an absolute serum creatinine level ≥ 0.5 mg/dL or a 25% increase in the serum creatinine level compared with the baseline level within 48 hours after the administration of contrast medium was defined as CIN.
RESULTS: The Synergy Between Percutaneous Coronary Interventions With Taxus and Cardiac Surgery score (SYNTAX [SS]) and log CSS were higher in patients with CIN than in those without. In the multivariate analysis, log CSS (odds ratio, 1.405, 95% confidence interval, 1.318-1.497; P < 0.001), hemoglobin, and contrast volume were found to be independent predictors of CIN. In the receiver operating characteristic analysis, a log CSS > 9.5 had a 74.5% sensitivity and a 90.5% specificity for predicting CIN, with an area under the curve (AUC) of 0.892, whereas an SS > 18.5 had a 64% sensitivity, a 58.1% specificity, and an AUC of 0.625 (0.892 vs 0.625; P < 0.001). A log CSS > 9.5 was associated with in-hospital and long-term mortality, reinfarction, revascularization, and in-hospital hemodialysis (P < 0.001 for each).
CONCLUSIONS: The log CSS may improve the accuracy of risk stratification for the development of CIN in patients undergoing pPCI.
Copyright © 2016 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26255218     DOI: 10.1016/j.cjca.2015.05.005

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  6 in total

1.  The Impact of Lesion Complexity and the CHA2DS2-VASc Score on Spontaneous Reperfusion in Patients with ST-Segment Elevation Myocardial Infarction.

Authors:  Gökhan Alıcı; Hasan Ali Barman; Adem Atıcı; Sevil Tuğrul; Ömer Genç; İrfan Şahin
Journal:  Int J Clin Pract       Date:  2022-02-09       Impact factor: 3.149

2.  Preprocedural Prediction Model for Contrast-Induced Nephropathy Patients.

Authors:  Wen-Jun Yin; Yi-Hu Yi; Xiao-Feng Guan; Ling-Yun Zhou; Jiang-Lin Wang; Dai-Yang Li; Xiao-Cong Zuo
Journal:  J Am Heart Assoc       Date:  2017-02-03       Impact factor: 5.501

3.  Risk Factors Associated With Contrast-Induced Nephropathy after Primary Percutaneous Coronary Intervention.

Authors:  Dileep Kumar; Hussain Liaquat; Jawaid A Sial; Tahir Saghir; Rekha Kumari; Hitesh Kumar; Musa Karim; Kelash Rai; Reeta Bai
Journal:  Cureus       Date:  2020-08-13

4.  CHA2DS2-VASc, a Simple Clinical Score Expanding Its Boundaries to Predict Contrast-Induced Acute Kidney Injury After Primary Percutaneous Coronary Interventions.

Authors:  Rajesh Kumar; Mahesh Kumar Batra; Sanam Khowaja; Ali Ammar; Ashok Kumar; Jehangir Ali Shah; Jawaid Akbar Sial; Tahir Saghir; Musa Karim
Journal:  Int J Nephrol Renovasc Dis       Date:  2021-12-31

5.  Association between Contrast Media Volume and 1-Year Clinical Outcomes in Patients Undergoing Coronary Angiography.

Authors:  Ying-Qing Feng; Xu-Yu He; Fei-Er Song; Ji-Yan Chen
Journal:  Chin Med J (Engl)       Date:  2018-10-20       Impact factor: 2.628

6.  Does contrast media volume affect long-term survival in patients with chronic kidney disease?

Authors:  Ismail Biyik; Fatih Uzun; Mehmet Erturk; Derya Ozturk; Ali Kemal Kalkan; Ertan Akbay; Gulsah Akture; Mucahit Emet; Ahmet Arif Yalcin; Ibrahim Faruk Akturk
Journal:  Arch Med Sci Atheroscler Dis       Date:  2017-11-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.